Paul McBarron
Finanzdirektor/CFO bei CYCLACEL PHARMACEUTICALS, INC.
Vermögen: 25 986 $ am 30.04.2024
Aktive Positionen von Paul McBarron
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.03.2006 | - |
| Geschäftsführer | 01.01.2002 | - | |
| Finanzdirektor/CFO | 01.01.2002 | - | |
| Investor Relations Kontakt | - | - | |
| Public Communications Contact | - | - | |
| Unternehmenssekretär | 01.01.2002 | - | |
| Comptroller/Controller/Auditor | 01.01.2002 | - |
Karriereverlauf von Paul McBarron
Ehemalige bekannte Positionen von Paul McBarron
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Cyclacel Group Plc
 Cyclacel Group Plc Pharmaceuticals: MajorHealth Technology Cyclacel Group Plc designs and develops small molecule drugs. The company developed small molecule drugs act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. Cyclacel Group Plc was founded by Professor Sir David Lane in 1996 and is headquartered in Dundee, UK. | Geschäftsführer | 01.01.2002 | 15.10.2008 |
| Unternehmenssekretär | 01.01.2002 | 15.10.2008 | |
| SHIRE | Comptroller/Controller/Auditor | 01.01.1996 | 01.01.2001 |
| Finanzdirektor/CFO | 01.01.1996 | 01.01.2001 | |
Scottish Lifesciences Association
 Scottish Lifesciences Association Miscellaneous Commercial ServicesCommercial Services The Scottish Lifesciences Association operates an association for life sciences companies and organizations. | Direktor/Vorstandsmitglied | - | - |
Statistik
International
| Vereinigtes Königreich | 3 |
| Vereinigte Staaten | 2 |
| Irland | 2 |
Operativ
| Chief Operating Officer | 2 |
| Corporate Secretary | 2 |
| Comptroller/Controller/Auditor | 2 |
Sektoral
| Health Technology | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Cyclacel Group Plc
Cyclacel Group Plc Pharmaceuticals: MajorHealth Technology Cyclacel Group Plc designs and develops small molecule drugs. The company developed small molecule drugs act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. Cyclacel Group Plc was founded by Professor Sir David Lane in 1996 and is headquartered in Dundee, UK. | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Scottish Lifesciences Association
Scottish Lifesciences Association Miscellaneous Commercial ServicesCommercial Services The Scottish Lifesciences Association operates an association for life sciences companies and organizations. | Commercial Services |
- Börse
- Insiders
- Paul McBarron
- Erfahrung
